Erythroblast iron metabolism in sideroblastic marrows.
The uptake of iron by bone marrow erythroblasts and its intracellular distribution have been studied in 23 patients with primary sideroblastic anaemia (SA), five patients with secondary SA and one patient with only non-ringed sideroblasts. EM of erythroblasts from 18 cases showed both mitochondrial iron deposits and cytoplasmic ferritin aggregates in all cases except the patient with only non-ringed sideroblasts. Iron uptake by erythroblasts in whole bone marrow was normal but there was a decreased incorporation into haem and an increased incorporation into cell stroma. Age matching of erythroblasts using Percoll density gradient centrifugation indicated that stromal iron incorporation was high at all stages of erythroblast development even before haem synthesis had become a major metabolic activity and in intermediate and late erythroblasts a real decrease in haem synthesis appeared less certain. These observations, together with the inability to correct the abnormality in vitro with either pyridoxal phosphate or delta amino-laevulinic acid suggest that the primary defect in SA may be an abnormality of mitochondrial iron metabolism rather than an abnormality of haem synthesis.
D000328:Adult; D000368:Aged; D000622:Aminolevulinic Acid / Q000494:pharmacology; D000756:Anemia, Sideroblastic / Q000378:metabolism*; D001853:Bone Marrow / Q000378:metabolism*; D003593:Cytoplasm / Q000378:metabolism; D004900:Erythroblasts / Q000378:metabolism*; D004909:Erythrocyte Indices; D004912:Erythrocytes / Q000378:metabolism*; D004921:Erythropoietin / Q000378:metabolism; D005260:Female; D005293:Ferritins / Q000378:metabolism; D006418:Heme / Q000378:metabolism; D006801:Humans; D007501:Iron / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D008928:Mitochondria / Q000378:metabolism; D011732:Pyridoxal Phosphate / Q000494:pharmacology
D004921:Erythropoietin; D006418:Heme; D011732:Pyridoxal Phosphate; D000622:Aminolevulinic Acid; D005293:Ferritins; D007501:Iron